This study provides a comprehensive analysis of the United States federal and Minnesota state Research and Development (R&D) tax credit requirements as they apply to the industrial ecosystem of Rochester, Minnesota[cite: 1]. It explores statutory frameworks, emerging case law, and rigorous reporting mandates, detailing how local historical development intersects with these dual tax incentives across five unique industry case studies[cite: 1].

The Federal Research and Development Tax Credit Framework

The United States federal Research and Development tax credit, formally codified under Section 41 of the Internal Revenue Code (IRC), was permanently established to continuously encourage American businesses to invest heavily in technological innovation and retain highly skilled technical development within domestic borders[cite: 1]. The credit generally yields a direct, dollar-for-dollar reduction in a taxpayer’s federal income tax liability, structurally calculated as a percentage of Qualified Research Expenses (QREs) that exceed a strictly defined statutory base amount[cite: 1]. For companies spanning from nascent startups to established multinational conglomerates, navigating the federal R&D tax credit requires a meticulous, exhaustive understanding of legislative statutes, administrative guidance from the Internal Revenue Service (IRS), and an ever-evolving body of judicial precedent established by the United States Tax Court that increasingly interprets eligibility with intense scrutiny[cite: 1].

The Exhaustive Four-Part Test for Qualified Research Activities

To legally qualify for the federal R&D tax credit, a taxpayer must bear the burden of proof to demonstrate that the underlying day-to-day activities satisfy a stringent, statutorily defined four-part test under IRC Section 41(d)[cite: 1]. This rigorous test cannot be applied broadly to an entire company or even a whole department; it must be applied separately to each discrete business component being developed or improved through a principle known as the “shrinking back rule”[cite: 1].

The first component is the Section 174 Test, which mandates the elimination of uncertainty[cite: 1]. Under this requirement, the expenditures must be incurred directly in connection with the taxpayer’s active trade or business and represent genuine research and development costs in the experimental or laboratory sense[cite: 1]. The explicit and documented purpose of the activity must be to discover information that actively eliminates uncertainty concerning the development or improvement of a product or process[cite: 1]. The IRS Audit Techniques Guide clarifies that uncertainty exists if the information available to the taxpayer at the absolute outset of the project does not establish the capability, the methodology, or the appropriate design for developing or improving the business component[cite: 1]. As powerfully demonstrated in recent United States Tax Court rulings, a generalized assertion of industry-wide uncertainty is wholly insufficient; the uncertainty must be specific to the taxpayer’s particular undertaking[cite: 1]. In the landmark 2024 case Phoenix Design Group, Inc. v. Commissioner, the Tax Court ruled against the taxpayer precisely because they failed to document specific uncertainties regarding capability or design prior to the commencement of the research[cite: 1]. Taxpayers are now on notice that the IRS expects clear, contemporaneous documentation of technological uncertainty defined at the project’s inception[cite: 1].

The second component is the Discovering Technological Information Test[cite: 1]. This statutory requirement demands that the research must be undertaken to discover information that is fundamentally technological in nature[cite: 1]. This explicitly requires the process of experimentation to rely upon the established principles of the hard sciences, specifically limited to physics, chemistry, biology, computer science, or engineering[cite: 1]. While historical iterations of the final treasury regulations previously demanded a “discovery rule”—requiring that the knowledge must exceed, expand, or refine the common knowledge of skilled professionals within the broader industry—this has been abandoned[cite: 1]. The current standard merely requires that the technological information be new to the taxpayer[cite: 1]. However, the statute explicitly excludes research relying upon the social sciences, arts, or humanities[cite: 1]. For example, the IRS Audit Techniques Guide notes that researching the historical life of a painter is excluded, whereas utilizing chemistry to develop a new formulation of durable artist’s paint would qualify, emphasizing that the underlying scientific process governs eligibility rather than the final aesthetic result[cite: 1].

The third component is the Business Component Test[cite: 1]. The application of the research activities must be intended to be useful in the development of a new or improved business component for the taxpayer[cite: 1]. The Internal Revenue Code comprehensively defines a “business component” as any specific product, process, computer software, technique, formula, or invention that is held for sale, lease, license, or actively used by the taxpayer in their own trade or business[cite: 1]. To survive an IRS examination, the taxpayer must be able to establish a direct, unbreakable nexus tying the claimed research activities and the associated Qualified Research Expenses specifically to the relevant business component[cite: 1].

The fourth and most heavily litigated component is the Process of Experimentation Test[cite: 1]. The statute dictates that “substantially all” of the activities must constitute elements of a process of experimentation conducted for a qualified purpose[cite: 1]. A qualified purpose must relate fundamentally to a new or improved function, performance, reliability, or quality, rather than mere aesthetic or cosmetic changes[cite: 1]. Legally, the term “substantially all” is strictly defined as 80 percent or more of the research activities[cite: 1]. This requires the taxpayer to design and execute a systematic process designed to evaluate one or more alternatives to achieve a result where the capability, method, or design is uncertain at the beginning[cite: 1]. The core elements of this iterative process include identifying the baseline uncertainty, identifying specific scientific alternatives to eliminate that uncertainty, and conducting a rigorous evaluative process, such as advanced computational modeling, physical simulation, or systematic trial and error[cite: 1]. The judicial enforcement of this standard is uncompromising[cite: 1]. In the 2021 case Little Sandy Coal Co., Inc. v. Commissioner, the Tax Court denied substantial R&D tax credits because the company failed to provide quantitative evidence proving that at least 80 percent of their research followed a structured, documented process of experimentation[cite: 1]. The ruling signaled to the tax community that the IRS will vigorously enforce the mathematical threshold of the “substantially all” requirement, demanding real-time documentation, design iterations, and engineering notes[cite: 1].

Qualified Research Expenses (QREs) and Statutory Exclusions

If a taxpayer successfully navigates the four-part test for a specific business component, they must then quantify their Qualified Research Expenses[cite: 1]. Under IRC Section 41(b)(1), QREs are strictly limited to the sum of in-house research expenses and contract research expenses[cite: 1]. If an expenditure does not fit perfectly within these statutorily defined categories, a taxpayer is legally prohibited from claiming it as a QRE[cite: 1].

In-house research expenses encompass taxable wages paid or incurred to an employee for performing qualified services[cite: 1]. For Section 41 purposes, “wages” refers specifically to taxable wages as defined in Section 3401(a) and reported on a Form W-2, which can include performance bonuses and stock option redemptions if they are subject to withholding[cite: 1]. Non-taxed fringe benefits are entirely excluded[cite: 1]. Qualified services are categorized into three distinct buckets: engaging in qualified research (the actual conduct of the science, such as a lab technician running assays), direct supervision (first-line, immediate management of the researchers, excluding upper-level executives), and direct support (services that directly support the research, such as a machinist fabricating an experimental prototype part or a clerk compiling laboratory data)[cite: 1]. General administrative services, such as corporate payroll processing or janitorial services, are disqualified[cite: 1]. Similar to the process of experimentation test, wages are subject to a “substantially all” rule: if 80 percent or more of an employee’s total annual hours are dedicated to qualified services, then 100 percent of their W-2 wages may be captured as QREs[cite: 1].

In addition to wages, in-house expenses include amounts paid for “supplies” used directly in the conduct of qualified research[cite: 1]. Section 41(b)(2)(C) narrowly defines a supply as any tangible property other than land, improvements to land, and property subject to an allowance for depreciation[cite: 1]. This means that raw materials consumed or destroyed during prototype testing qualify, but the purchase of a depreciable piece of laboratory equipment, such as a mass spectrometer or a robotic welding arm, does not[cite: 1]. Travel, meals, telephone expenses, and licensing fees are also statutorily excluded from the supply definition[cite: 1].

Contract research expenses allow taxpayers to claim 65 percent of any amount paid or incurred to a third-party person or entity for qualified research[cite: 1]. This percentage acts as a statutory proxy to remove the contractor’s profit margin and overhead from the credit calculation[cite: 1]. Under Treasury Regulation Section 1.41-2(e), this expense only qualifies if it is paid pursuant to an agreement that is entered into prior to the performance of the research, provides that the research is performed on behalf of the taxpayer (ensuring the taxpayer retains substantial rights to the intellectual property), and requires the taxpayer to bear the financial expense even if the research is ultimately unsuccessful[cite: 1]. If a contract dictates that the third party is only paid upon the successful delivery of a working prototype, the arrangement is viewed as a payment for a product rather than a payment for research, and the expenses are utterly disqualified[cite: 1]. Notably, IRC Section 41(b)(3)(C) provides an enhanced incentive for collaborative research; the eligible percentage is increased from 65 percent to 75 percent for amounts paid to a “qualified research consortium,” defined as a tax-exempt organization organized and operated primarily to conduct scientific research on behalf of the taxpayer and unrelated entities[cite: 1].

Even if an activity meets the four-part test and generates QREs, the Internal Revenue Code carves out severe statutory exclusions[cite: 1]. Routine data collection, management functions, efficiency surveys, the preparation of financial data, and market research are disqualified[cite: 1]. Any research conducted outside the physical boundaries of the United States, Puerto Rico, or any U.S. possession is strictly excluded, regardless of whether the researchers are American citizens or performing work for an American corporation[cite: 1]. Furthermore, the development of “internal-use software” (software developed primarily for the taxpayer’s own internal administrative or operational functions) faces an incredibly steep barrier to entry[cite: 1]. To qualify, internal-use software must meet the standard four-part test plus an additional three-part “high threshold of innovation” test, which requires the taxpayer to prove that the software is highly innovative, involves significant economic and technical risk, and is not commercially available for purchase[cite: 1].

The Shifting Landscape of Compliance, Form 6765, and Section 174 Amortization

The administrative and compliance landscape governing the federal R&D credit has become overwhelmingly complex[cite: 1]. For tax years beginning in 2024, the IRS has introduced massive, proposed structural changes to Form 6765, Credit for Increasing Research Activities[cite: 1]. Historically, taxpayers could aggregate their total QREs and apply them to the mathematical formula[cite: 1]. The revised form fundamentally alters this paradigm by introducing exhaustive new reporting mandates, particularly Section G, which becomes mandatory for most taxpayers in 2025[cite: 1]. Section G requires taxpayers to report highly granular, disaggregated data for every single business component claiming the credit[cite: 1]. Taxpayers must explicitly identify the specific research activities performed per component, identify all individuals who performed each activity, define the exact scientific information sought to discover, and break out the precise wages, supplies, and contract expenses allocated to that specific component[cite: 1]. This new level of required transparency will force companies to overhaul their internal payroll and project management software to track expenditures at a microscopic level[cite: 1].

Simultaneously, taxpayers must navigate the severe accounting changes triggered by the Tax Cuts and Jobs Act (TCJA) of 2017[cite: 1]. Historically, under IRC Section 174, businesses could immediately deduct 100 percent of their R&D expenses in the year they were incurred, providing an immediate reduction in taxable income[cite: 1]. The TCJA revoked this immediate expensing provision[cite: 1]. For tax years beginning after December 31, 2021, businesses are now legally required to capitalize all Specified Research or Experimental Expenditures (SREs) and amortize those costs ratably over a mandatory period of five years for domestic research, or fifteen years for foreign research[cite: 1]. Revenue Procedure 2025-8 provides updated procedural guidance for taxpayers to file an automatic change of accounting to comply with these amortization mandates, effectively forcing businesses to spread their tax deductions over half a decade, significantly impacting short-term corporate cash flow[cite: 1].

The IRS has also adopted a highly aggressive posture regarding amended returns and refund claims[cite: 1]. In the 2024 case Meyer, Borgman & Johnson, Inc. v. Commissioner, the IRS utilized a new internal “Classifier” review system to summarily deny a massive R&D tax credit refund claim before it ever reached a standard field examiner[cite: 1]. The Tax Court upheld the IRS’s right to demand bulletproof, exhaustive documentation mapped directly to business components at the moment of submission[cite: 1]. A weak, poorly documented claim will no longer survive initial administrative processing, rendering proactive audit defense an absolute necessity for all taxpayers[cite: 1].

The Minnesota State Research and Development Tax Credit Framework

In tight alignment with federal statutes, the State of Minnesota offers a robust incentive known as the Credit for Increasing Research Activities, codified under Minnesota Statute 290.068, designed to aggressively incentivize corporate investment, retain high-tech employment, and foster intellectual property development within its sovereign borders[cite: 1]. To qualify for the state credit, the expenditures must generally mirror the highly technical federal definitions of Qualified Research Expenses under IRC Section 41[cite: 1]. Therefore, a taxpayer must simultaneously satisfy the federal four-part test while navigating the state’s unique calculation mechanisms[cite: 1]. However, the Minnesota statute introduces one absolute, unyielding geographic constraint: all claimed research activities and their associated expenses must be conducted entirely within the physical boundaries of the state of Minnesota[cite: 1].

State Calculation Mechanisms and Judicial Interpretations of the Base Amount

The mathematical calculation of the Minnesota R&D credit operates on a tiered, incremental structure designed to reward companies that continuously increase their R&D spending year over year[cite: 1]. For taxable years beginning after December 31, 2016, the Minnesota state credit provides a highly lucrative 10 percent offset on the first $2,000,000 of qualifying expenses that exceed a statutorily calculated “base amount”[cite: 1]. For all excess qualifying expenses that surpass the $2,000,000 threshold, the credit drops to a 4 percent offset rate[cite: 1].

The definition, interpretation, and mathematical calculation of the “base amount” has historically been one of the most heavily litigated aspects of Minnesota tax law, requiring intervention by the Minnesota Supreme Court[cite: 1]. Conceptually, the base amount is calculated utilizing the complex federal fixed-base percentage rules outlined in IRC Section 41(c), which historically measures a company’s ratio of R&D spending to its gross receipts during a specific historical base period[cite: 1]. For state tax years after May 30, 2017, the aggregate gross receipts used in the calculation must be derived specifically from Minnesota sales or receipts as defined under section 290.191, creating a state-specific apportionment ratio[cite: 1].

The intricacies of this calculation were rigorously tested and definitively settled in two landmark companion cases decided by the Minnesota Supreme Court in 2019: General Mills, Inc. v. Commissioner of Revenue and International Business Machines Corporation v. Commissioner of Revenue[cite: 1]. In these highly publicized cases, massive multinational taxpayers argued over the interpretation of the statutory base amount[cite: 1]. The corporate taxpayers argued that the denominator of the fixed-base percentage formula should only utilize Minnesota-specific gross receipts[cite: 1]. By utilizing a much smaller, state-only revenue denominator, the multinational corporations could mathematically manipulate the formula to artificially lower their historical base amount, thereby vastly inflating their current-year incremental R&D credit[cite: 1].

The Minnesota Supreme Court unequivocally rejected the taxpayers’ arguments and affirmed the Tax Court’s decision in favor of the Commissioner of Revenue[cite: 1]. The Supreme Court ruled that the Minnesota Legislature implicitly incorporated the federal “minimum base amount” limitation into the state statute, a critical rule which dictates that a company’s base amount can never be less than 50 percent of its current year’s QREs, establishing a hard floor to limit massive credit windfalls[cite: 1]. Furthermore, the Court held that for the tax years in question, the term “aggregate gross receipts” used in the denominator of the fixed-base percentage formula legally referred to the taxpayer’s total federal aggregate gross receipts, not strictly Minnesota aggregate gross receipts[cite: 1]. This landmark ruling structurally prevented large, national corporations operating facilities in Minnesota from exploiting state-apportionment math against national R&D baselines[cite: 1]. Additionally, the Minnesota Supreme Court continues to enforce strict adherence to the scientific nature of the credit[cite: 1]. In the 2024 case Uline, Inc. v. Commissioner of Revenue, the Court affirmed that routine marketing research performed by sales representatives does not qualify for protection or tax advantages under state provisions, reinforcing the absolute exclusion of non-technical, social science research[cite: 1].

Transformational Legislative Changes: House File 9 and Partial Refundability (2025)

Historically, the Minnesota Credit for Increasing Research Activities operated strictly as a non-refundable tax credit[cite: 1]. This meant that if a company generated an R&D credit that mathematically exceeded its current-year state income or corporate franchise tax liability, the State of Minnesota would not issue a refund check for the difference[cite: 1]. Instead, the taxpayer was forced to carry the unused credit forward, banking it for up to 15 years to offset future tax liabilities[cite: 1]. While beneficial for highly profitable legacy corporations, this structure provided zero immediate financial utility to pre-revenue biotech startups, early-stage software developers, and capital-intensive manufacturers operating at a net loss during their multi-year product development cycles[cite: 1].

This restrictive paradigm was entirely transformed with the passage of House File 9 (H.F. 9), a sweeping legislative overhaul signed into law by Minnesota Governor Tim Walz on June 14, 2025[cite: 1]. H.F. 9 revolutionized the state incentive by introducing partial refundability for the very first time, applicable to tax years beginning after December 31, 2024[cite: 1]. This landmark amendment allows eligible taxpayers—including C corporations, pass-through entities, estates, individuals, and trusts—to elect to receive an immediate cash refund from the Department of Revenue for a portion of their unused R&D credits rather than carrying the full amount forward[cite: 1].

The refundable amount is mathematically determined by multiplying the taxpayer’s unused credit by a phased “applicable refundability rate” established by the legislature[cite: 1]:

• 19.2 percent refundability rate for tax years beginning after December 31, 2024, and before January 1, 2026[cite: 1].
• 25 percent refundability rate for tax years beginning after December 31, 2025, and before January 1, 2028[cite: 1].
• Post-2027 structure, where the refund rate will be the lesser of 25 percent or a variable projected rate published annually by the state by December 27[cite: 1]. This floating rate is explicitly designed to cap the total aggregate state R&D refunds at $25 million per year, protecting the state’s broader fiscal budget[cite: 1].

To utilize this mechanism, taxpayers must make an explicit, irrevocable election to claim the refundable portion on their timely filed state tax returns, including valid extensions[cite: 1]. Once the choice is made for a specific tax year, it cannot be reversed via an amended return[cite: 1]. Any portion of the unused credit that is not refunded under this calculation retains its standard 15-year carryforward status[cite: 1]. This legislative shift acts as a profound economic catalyst for the Rochester ecosystem, allowing heavily capitalized early-stage technology firms and pre-revenue life science ventures to monetize their R&D investments immediately, injecting critical non-dilutive capital directly back into their operations to fund further laboratory testing and engineering payroll[cite: 1].

The Economic Evolution and Industrial Architecture of Rochester, Minnesota

Situated strategically in the southeastern quadrant of the state, Rochester’s economy historically relied entirely upon the agrarian output of the surrounding plains and the critical expansion of the Chicago & Northwestern Transportation Company railroad in the 1860s, which connected local farmers to national commodity markets[cite: 1]. However, the entire socioeconomic trajectory of the city was permanently altered by a catastrophic natural disaster[cite: 1]. On August 21, 1883, a massive, violent tornado swept across the rolling plains and devastated the regional urban center, killing 24 people, injuring over 100, and obliterating more than 150 buildings[cite: 1].

The ensuing medical crisis overwhelmed the local infrastructure, prompting Dr. William Worrall Mayo—a physician serving as the examining surgeon of federal draftees during the Civil War—his medically trained sons, and the Sisters of Saint Francis to collaborate on the establishment of a permanent medical facility to treat the wounded[cite: 1]. This emergency partnership laid the foundational architecture for the Mayo Clinic, culminating in the opening of St. Marys Hospital in 1889 with a mere 27 beds[cite: 1]. By continuously recruiting top-tier physicians and aggressively developing scientific laboratories to test and refine medical knowledge, the Mayo partnership established Rochester as an unprecedented global nexus for medical technology, patient care, and clinical research[cite: 1].

In the post-World War II era, the city experienced a second, equally massive paradigm shift with the arrival of the International Business Machines Corporation (IBM)[cite: 1]. In 1956, IBM CEO Thomas Watson Jr. selected Rochester—honoring his friend and Rochester native, Leland Fiegel—to construct a colossal manufacturing and training facility on 400 acres of farmland[cite: 1]. Designed by the legendary architect Eero Saarinen, the facility—famously known as “Big Blue” due to its distinctive blue facade and massive footprint resembling a computer chip from the air—enclosed 3.6 million square feet under a single roof[cite: 1]. The opening of the plant sparked a massive building boom in Rochester, adding over 20,000 residents to the city’s population by 1970[cite: 1]. IBM Rochester became a prolific, world-renowned center for technological invention[cite: 1]. The facility’s engineers birthed the System 3 computer in 1969, introduced the world to the modern floppy disk in 1973, and developed the legendary AS/400 mid-range computer architecture[cite: 1]. By 1990, the facility employed over 8,000 workers, generated dozens of complex patents annually, and received the Malcolm Baldrige National Quality Award[cite: 1].

The dual gravitational pull of the Mayo Clinic’s medical demand and IBM’s massive logistical supply chain catalyzed intense secondary industrial growth across the entire region[cite: 1]. A robust, highly specialized ecosystem of advanced manufacturing emerged to support heavy industry, leading to the rise and expansion of massive metalworking firms like Crenlo Engineered Cabs and McNeilus Truck & Manufacturing in the broader Rochester/Dodge Center area[cite: 1]. Concurrently, the region’s rich agricultural heritage underwent a sophisticated evolution[cite: 1]. Between 1900 and 1950, a rising U.S. population and changing consumer preferences transformed raw agriculture into highly engineered food processing networks[cite: 1]. Flour millers and meatpackers evolved into packaged food conglomerates, anchoring national giants like Seneca Foods and Kemps deeply within the Rochester economy[cite: 1].

Today, Rochester possesses a hyper-diverse, fiercely resilient, knowledge-based economy[cite: 1]. It is no longer reliant on a single industry but is instead supported by interconnected pillars of healthcare, advanced heavy manufacturing, computer technology, bio-science, and food processing[cite: 1]. This unique historical convergence of extreme medical necessity, massive corporate computing investment, and agricultural abundance has created an industrial environment perfectly primed to generate Qualified Research Expenses under the strict statutes of the United States and Minnesota tax codes[cite: 1].

Five Unique Industry Case Studies in Rochester, Minnesota

The following five exhaustive case studies examine specific industries deeply rooted in Rochester’s unique geographic and historical development[cite: 1]. Each case study details exactly why and how the industry flourishes in the region, and provides a highly technical analysis of how a hypothetical local corporate entity within that sector could navigate the rigorous federal four-part test and leverage the Minnesota R&D tax credit requirements[cite: 1].

Healthcare and Medical Technology (The Mayo Clinic Legacy)

Historical Context and Regional Development: The medical technology sector in Rochester is inextricably linked to the historical genesis of the Mayo Clinic following the catastrophic 1883 tornado[cite: 1]. Over the course of a century, the Mayo Clinic’s revolutionary model of integrated clinical practice, peer-reviewed education, and relentless laboratory research transformed Rochester from an agrarian stop on the Chicago & Northwestern railway into a global incubator for advanced medical devices and clinical technology[cite: 1]. The sheer density of clinical expertise requires constant technological innovation to diagnose and treat complex pathologies[cite: 1]. Today, this legacy is aggressively expanded through the “Destination Medical Center” (DMC) initiative[cite: 1]. As the largest public-private economic development initiative in Minnesota, the DMC serves as an economic catalyst to attract biotech entrepreneurs, students, and educators from across the globe, fostering a collaborative environment where private medical device engineering is deeply enmeshed with frontline clinical insight within a 16-block sub-district known as Discovery Square[cite: 1].

Tax Credit Eligibility and Technical Analysis: Consider a highly specialized Rochester-based medical device manufacturer seeking to develop a next-generation pressure-regulating fluid pump intended for complex hysteroscopic surgeries[cite: 1]. To legally capture the federal R&D tax credit under IRC Section 41, the company’s engineers must rigorously apply the four-part test specifically to this discrete business component[cite: 1].

• Section 174 Test (Elimination of Uncertainty): At the absolute outset of the project, the mechanical engineering team encounters severe technical uncertainty regarding the accuracy of input and output fluid measurements, the physical capability to maintain the required flow rate without experiencing instantaneous pressure variances, and ensuring real-time digital monitoring of potentially harmful fluid loss inside the surgical cavity[cite: 1]. By documenting these precise, unresolved engineering variables in project charters before drafting the first blueprint, the firm fully satisfies the legal precedent established by Phoenix Design Group, which demands the establishment of specific technological uncertainties before physical development begins[cite: 1].
• Discovering Technological Information: The research relies fundamentally upon the hard-science principles of mechanical engineering, fluid dynamics, thermodynamics, and embedded software engineering, easily satisfying the requirement that the information be technological in nature[cite: 1].
• Business Component Test: The newly designed pressure-regulating pump itself constitutes a new product held for commercial sale to global hospital networks, establishing a clear, indisputable business component[cite: 1].
• Process of Experimentation: To systematically eliminate the fluid dynamic uncertainties, the firm engages in a rigorous, iterative process[cite: 1]. They begin with advanced software CAD modeling, move to the physical fabrication of varied pump prototypes incorporating a unique pressure regulating loop, and conclude with destructive clinical stress testing to achieve stringent FDA safety compliance[cite: 1]. Over 80 percent of the engineering labor hours are mathematically dedicated to this systematic trial-and-error evaluative process, adhering strictly to the precedent set by the Tax Court in Little Sandy Coal[cite: 1].

State-Level Implications and Compliance: Because the mechanical engineering design, the proprietary software coding for the pump’s firmware, and the physical prototype testing are conducted entirely within the physical city limits of Rochester, the associated Qualified Research Expenses—including the highly compensated localized W-2 wages of the mechanical engineers and the physical supplies consumed in destructive prototype testing—legally qualify for the Minnesota Credit for Increasing Research Activities under Statute 290.068[cite: 1]. Furthermore, if this medical device startup operates at a massive net loss during the prolonged, multi-year FDA clinical approval cycle, the transformational 2025 H.F. 9 legislation allows the firm to formally elect a 19.2 percent cash refund on its generated state credits[cite: 1]. This legislative mechanism provides vital, immediate cash liquidity to fund further iterative clinical trials and pay ongoing engineering salaries, rather than forcing the startup to carry an unusable paper credit forward for 15 years[cite: 1].

Computer Hardware and Software Engineering (The IBM Phenomenon)

Historical Context and Regional Development: Computer engineering and advanced software architecture became a permanent cornerstone of Rochester’s economy when IBM opened its massive manufacturing and training facility in 1956[cite: 1]. By the late 1980s and early 1990s, the Saarinen-designed facility was an epicenter of global computing, employing over 8,000 individuals and generating dozens of complex patents annually[cite: 1]. The facility birthed the legendary AS/400 mid-range computer system, fundamentally pioneered hard disk development, and created the world’s first floppy disk[cite: 1]. While IBM’s physical manufacturing footprint eventually declined and the 3-million-square-foot property was sold in 2018 to Industrial Realty Group, the decades-long presence of “Big Blue” seeded the entire Rochester region with an extraordinarily highly specialized, multi-generational workforce trained in rigorous systems engineering[cite: 1]. This deep talent pool continues to drive modern software development, cybersecurity, and hardware engineering startups across the city today[cite: 1].

Tax Credit Eligibility and Technical Analysis: Consider a local Rochester software engineering firm contracted by a national healthcare network to develop a novel, highly complex machine learning algorithm and interoperability API designed to process, analyze, and securely transmit massive Electronic Health Record (EHR) datasets across diverse, legacy hospital mainframes[cite: 1].

• Section 174 Test (Elimination of Uncertainty): The software firm faces extreme, specific uncertainty regarding whether predictive diagnostic algorithms can be successfully integrated into the hospital’s legacy EHR systems without introducing severe processing latency, corrupting the database architecture, or violating strict HIPAA data protection and encryption requirements[cite: 1].
• Discovering Technological Information: The development is grounded entirely in the hard sciences of computer science, advanced cryptography, and artificial intelligence neural network architectures[cite: 1].
• Business Component Test: The newly coded predictive algorithm and the interoperability software API constitute new software architectures developed specifically for commercial licensing[cite: 1].
• Process of Experimentation: The firm undergoes iterative, exhaustive cycles of algorithm training, validation against disparate medical imaging datasets, simulated penetration testing to ensure data security, and performance latency benchmarking to eliminate the identified architectural uncertainties[cite: 1].

A critical legal compliance factor for software engineering firms involves the Internal-Use Software (IUS) exclusion[cite: 1]. If the software is intended solely for the firm’s own general administrative functions (e.g., a new HR tracking tool), it faces the grueling “high threshold of innovation” test[cite: 1]. However, because this algorithm is intended for commercial licensing and integration into third-party healthcare networks, it escapes the IUS gauntlet entirely, being judged on the standard four-part test[cite: 1]. Furthermore, under the TCJA’s Section 174 accounting mandates, the firm is explicitly required to capitalize and amortize all of its software developer wages and development costs over five years, significantly altering their short-term corporate tax burden and cash flow modeling[cite: 1].

State-Level Implications and Compliance: For the Minnesota state R&D credit, the software firm must accurately calculate its historical base amount[cite: 1]. Under the landmark IBM v. Commissioner state supreme court ruling, if this firm generates revenue nationally but executes all software development within Rochester, it must utilize its total federal aggregate gross receipts in the denominator of the fixed-base percentage formula[cite: 1]. This prevents the firm from artificially lowering its base amount by isolating only Minnesota-based software sales, ensuring complete compliance with the state’s highest judicial precedents regarding statutory definitions[cite: 1].

Advanced Food Processing (Agricultural Roots and Seneca Foods)

Historical Context and Regional Development: Southeastern Minnesota’s economy is deeply rooted in massive agricultural production[cite: 1]. Between 1900 and 1950, shifting demographics and an increasingly urbanizing consumer market necessitated the evolution of raw agriculture into highly engineered, value-added food processing networks[cite: 1]. The region’s robust infrastructure allowed local produce and dairy to be chemically transformed into shelf-stable commodities[cite: 1]. Flour millers evolved into packaged food conglomerates like General Mills, while meat processors like Hormel engineered products like SPAM[cite: 1]. This fertile industrial environment fostered the massive growth of companies like Kemps and Seneca Foods in the Rochester area[cite: 1]. Seneca Foods, originating from an acquired failing grape juice company in 1949, pioneered frozen grape juice co-packing with Minute Maid and eventually acquired a major cannery in southeast Rochester in 1982 (a historic facility originally opened in 1929)[cite: 1]. This facility historically drove regional innovations in canning thermodynamics, freezing, and packaging automation before Seneca shifted operations to adapt to modern supply chains[cite: 1].

Tax Credit Eligibility and Technical Analysis: Consider a modern Rochester-based food processing and engineering company seeking to develop a novel, highly shelf-stable, plant-based nutritional beverage that requires an entirely proprietary pasteurization process and a custom-built automated packaging line[cite: 1].

• Section 174 Test (Elimination of Uncertainty): The company lacks the fundamental scientific knowledge regarding the precise thermal threshold and sustained temperature duration required to completely eliminate microbial growth without degrading or denaturing the delicate, plant-based protein structures suspended in the beverage[cite: 1]. Furthermore, immense uncertainty exists regarding the mechanical engineering design of a high-volume automated packaging line capable of maintaining a perfectly sterile vacuum environment during fluid injection[cite: 1].
• Discovering Technological Information: The beverage formulation relies heavily upon the hard sciences of food chemistry, microbiology, and thermodynamics, while the design of the packaging line relies upon mechanical and systems engineering[cite: 1].
• Business Component Test: The firm establishes two distinct business components: the new product formulation (the physical beverage itself) and the new manufacturing process (the automated packaging line machinery)[cite: 1].
• Process of Experimentation: To solve the problems, the food scientists conduct systemic, rigorous batch testing, carefully manipulating thermal variables, acidity/pH levels, and fluid viscosity metrics[cite: 1]. Simultaneously, the manufacturing engineers execute trial runs of the robotic packaging components, engaging in destructive physical testing of the aluminum seals and utilizing biological sterility assays to ensure commercial viability and safety compliance[cite: 1].

It is absolutely vital to note that purely aesthetic changes—such as testing a new consumer label design or tweaking the flavor profile to be slightly sweeter without encountering underlying chemical uncertainty—are expressly excluded from federal R&D qualification[cite: 1]. The IRS Audit Techniques Guide clearly states that the process must rely on hard science, not culinary taste testing[cite: 1].

State-Level Implications and Compliance: The firm can simultaneously claim the federal credit and the Minnesota state credit for the experimental trial runs conducted entirely within its Rochester pilot plant[cite: 1]. The vast amounts of raw materials consumed, contaminated, or destroyed directly during these failed batch tests (e.g., raw plant proteins, experimental packaging films, test batches of the beverage) legally qualify as consumable supply QREs under both federal and state statutes, yielding a massive tax benefit that offsets the cost of wasted experimental materials[cite: 1].

Heavy Manufacturing (McNeilus and Crenlo Engineered Cabs)

Historical Context and Regional Development: The massive, decades-long presence of major industrial players like IBM required immense logistical, infrastructural, and heavy manufacturing support, laying the permanent groundwork for advanced heavy fabrication in the region[cite: 1]. Crenlo Engineered Cabs was founded in Rochester in 1951, initially engineering and producing the very first operator cabs for heavy-duty Caterpillar and John Deere machinery[cite: 1]. Similarly, McNeilus Truck & Manufacturing was founded in the nearby Dodge Center/Rochester area in 1970 by Garwin McNeilus, eventually evolving through aggressive engineering innovation into the world’s largest manufacturer of concrete mixers and refuse collection vehicles before being acquired by Oshkosh Corporation[cite: 1]. The massive operational presence of these manufacturing titans established a highly skilled, localized labor force deeply specialized in robotic welding, metal fabrication, and complex mechanical design[cite: 1].

Tax Credit Eligibility and Technical Analysis: Consider a regional heavy manufacturer operating in Rochester specializing in engineered cabs for massive off-highway utility and forestry vehicles[cite: 1]. The firm seeks to fundamentally redesign an operator cab utilizing advanced, lightweight composite metal alloys to drastically improve the vehicle’s fuel efficiency without compromising strict, federally mandated Rollover Protective Structure (ROPS) safety standards[cite: 1].

• Section 174 Test (Elimination of Uncertainty): The manufacturer faces specific, highly technical design and capability uncertainties regarding the tensile strength, the flexural modulus, and the automated robotic welding properties of the newly formulated composite alloys under extreme stress and torque[cite: 1].
• Discovering Technological Information: The research activity relies entirely on the hard sciences of materials science, advanced metallurgy, and mechanical engineering[cite: 1].
• Business Component Test: The newly designed, lightweight operator cab constitutes a discrete, tangible product held for commercial sale[cite: 1].
• Process of Experimentation: The firm utilizes advanced software simulation (e.g., SolidWorks) for initial computational load-bearing feasibility studies[cite: 1]. Because software models cannot perfectly predict metallurgical failure, this is followed by the physical fabrication of expensive prototypes[cite: 1]. These prototypes undergo violent, destructive testing—including massive compression loads and rollover simulations—to physically measure the exact yield points of the composite welds until catastrophic failure occurs[cite: 1].

Under federal audit guidelines, IRS examiners heavily scrutinize “prototype” expenditures to ensure they do not improperly contain property subject to long-term depreciation[cite: 1]. Because the fabricated cab is ultimately crushed and destroyed during the ROPS testing, the immense material costs safely and legally qualify as consumable supply QREs[cite: 1]. If, however, the cab survived the testing and was subsequently sold to a customer, those material costs would be generally excluded from the credit calculation[cite: 1].

State-Level Implications and Compliance: Because the manufacturing firm incurs significant material waste and highly compensated localized engineering labor hours during this destructive testing in their Rochester facility, these massive QREs factor directly into the Minnesota credit base[cite: 1]. Should the company choose to utilize a specialized, third-party heavy machinery testing facility located across the border in Wisconsin or Iowa for specific crash dynamics, those specific contract expenses would be completely disqualified from the state credit calculation, emphasizing the strict, absolute geographic constraint of Minnesota Statute 290.068[cite: 1].

Life Sciences and Regenerative Medicine (The BioBusiness Center)

Historical Context and Regional Development: To aggressively capitalize on the massive volume of intellectual property originating from the Mayo Clinic’s clinical research, local Rochester government officials, the State of Minnesota, and private entities collaboratively broke ground on the Minnesota BioBusiness Center in downtown Rochester in 2007[cite: 1]. This $27 million, 150,000-square-foot, nine-story facility was specifically designed as a mixed-use incubator to prevent local bioscience startups from migrating to rival tech hubs in California or Massachusetts[cite: 1]. The facility features highly specialized, profoundly expensive infrastructure, including the Advanced Product Incubator (API)—a “lab within a lab” clean room that utilizes sophisticated particle-filtering equipment to eliminate microscopic air particles down to single-digit counts[cite: 1]. This pristine environment is absolutely necessary to facilitate the production of cellular and regenerative therapeutic products without biological contamination[cite: 1].

Tax Credit Eligibility and Technical Analysis: Consider a pre-revenue biotech startup located within the BioBusiness Center researching a highly novel protocol for stem cell differentiation designed to regenerate targeted human cardiovascular tissue[cite: 1].

• Section 174 Test (Elimination of Uncertainty): There is immense, fundamental scientific uncertainty regarding the precise sequence of molecular triggers, environmental conditions, and enzymatic reactions required to reliably induce stem cell differentiation into the targeted cardiovascular cell type without causing uncontrolled mutation or cellular death[cite: 1].
• Discovering Technological Information: The research relies strictly upon the biological hard sciences: cellular biology, advanced genetics, and molecular sciences[cite: 1].
• Business Component Test: The resulting regenerative stem cell therapy is a new biological product and process intended for clinical application and eventual FDA licensing[cite: 1].
• Process of Experimentation: Researchers conduct thousands of highly repetitive in-vitro biological assays, utilizing the API clean room’s expensive Sepax 2 RM cell separation systems, systematically altering environmental and chemical variables to isolate the correct, safe differentiation pathway[cite: 1].

A unique compliance factor for highly specialized biotech firms is the issue of funded research[cite: 1]. Federal rules strictly exclude research funded by grants or third parties where payment to the researcher is not contingent on the success of the science[cite: 1]. If this startup receives a federal research grant that simply pays for time and materials and does not require the return of funds if the biological assay completely fails, the financial risk lies with the government, not the taxpayer[cite: 1]. Therefore, the associated expenses cannot be legally claimed as QREs[cite: 1].

State-Level Implications and Compliance: Similarly, Minnesota Statutes specifically disallow expenditures funded by an Innovation Grant from the Minnesota Department of Employment and Economic Development (DEED) from qualifying for the state R&D credit[cite: 1]. However, for privately funded QREs—backed by venture capital or angel investors—the firm can claim the massive Minnesota credit[cite: 1]. Given that regenerative medicine startups often operate in a cash-burning phase for over a decade before achieving commercial revenue, the introduction of the H.F. 9 partial refundability clause is extraordinarily beneficial[cite: 1]. It completely transforms a previously dormant, unusable tax asset into an active, liquid funding mechanism capable of underwriting the exorbitant costs of API clean-room leasing and highly specialized biochemical supplies in downtown Rochester[cite: 1].

Strategic Audit Preparedness and Future Compliance Outlook

As the Internal Revenue Service and the Minnesota Department of Revenue tighten their administrative scrutiny and deploy advanced auditing technologies, businesses operating within Rochester’s vibrant innovation economy must approach R&D tax credit claims with a highly sophisticated framework for contemporaneous documentation[cite: 1]. The historical era of retroactive “R&D mining”—where aggressive consulting firms reconstruct estimated expenses years after a project’s completion using generic interviews—has been functionally terminated by aggressive legal and administrative actions[cite: 1].

A critical area of audit vulnerability is the consistency rule, outlined explicitly in Section 41(c)(5)(A) and detailed in Chapter 6 of the IRS Audit Techniques Guide[cite: 1]. This uncompromising rule requires taxpayers to calculate QREs and gross receipts for their historical base years using the exact same definitions, parameters, and accounting methodologies applied to the current credit year[cite: 1]. If an expense type is deemed unqualified by modern standards today, it must be surgically removed from the historical base calculation, regardless of the tax law that was in effect during that base period[cite: 1]. The burden of proof rests entirely on the taxpayer to establish these base year expenses through concrete record analysis, completely prohibiting the use of statistical extrapolation[cite: 1]. Failure to maintain the historical documentation to prove this consistency can result in total disallowance of the credit, as famously demonstrated in the precedent-setting case Research, Inc. v. United States, where the court destroyed a claim because the taxpayer had disposed of historical project records[cite: 1].

Furthermore, the imminent implementation of Section G on the radically revised Form 6765 will force taxpayers into a posture of extreme structural transparency[cite: 1]. Businesses in Rochester must fundamentally alter their payroll architectures and project tracking software to tag expenses down to the individual business component level in real time[cite: 1]. An engineer’s weekly timecard can no longer simply read a generic “Research & Development”; it must map specifically and quantifiably to the development of the “pressure-regulating hysteroscopic pump” or the “EHR machine learning algorithm” to survive the initial IRS Classifier review processes demonstrated in Meyer, Borgman & Johnson[cite: 1].

For Minnesota state compliance, corporate controllers must prepare for rigorous dual-track geographic accounting[cite: 1]. The state’s absolute geographic requirement dictates that all supply invoices, W-2 addresses, and contract invoices clearly and definitively indicate where the research was physically conducted[cite: 1]. If a Rochester-based manufacturing firm utilizes a Detroit-based contractor for a subset of computer modeling, those specific costs must be manually stripped from the state credit calculation while potentially remaining fully eligible for the federal calculation[cite: 1]. Finally, the new refundability election under H.F. 9 introduces a highly complex strategic financial planning element; CFOs and controllers must model out whether an immediate 19.2 percent cash injection today outweighs the long-term utility of carrying the full 100 percent credit forward to offset future, highly profitable tax years[cite: 1].

Final Thoughts

The intersection of the United States federal R&D tax code and Minnesota’s state-specific statutory provisions creates a complex, highly lucrative environment designed to subsidize the immense risks of technological innovation[cite: 1]. Rochester’s completely unique economic history—forged by deep agricultural roots, the unprecedented medical pioneering of the Mayo Clinic following a natural disaster, and the computational breakthroughs driven by IBM’s massive infrastructural investment—has fostered an industrial ecosystem perfectly aligned with the rigid technical requirements of IRC Section 41 and Minnesota Statute 290.068[cite: 1]. By meticulously navigating the four-part test, adhering to strict new Form 6765 reporting mandates, ensuring ironclad documentation for the consistency rule, and strategically leveraging the new, vital liquidity provided by Minnesota’s H.F. 9 refundability statutes, local enterprises across medical technology, heavy manufacturing, food science, computing, and regenerative medicine can secure substantial, non-dilutive capital to boldly underwrite the next generation of American technological advancement[cite: 1].

The information in this study is current as of the date of publication, and is provided for information purposes only[cite: 1]. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study[cite: 1]. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances[cite: 1].